Multiple Sclerosis News

A new report reveals two experimental vaccines show promise protecting against the "mono" virus, which also causes cancer and has been implicated as a potential trigger of MS.

That amount included over $63 billion in direct medical costs and $22 billion in indirect non-medical costs.

A new study suggests if you eat a lot of meat, you may be at increased risk for multiple sclerosis.

The new study of more than 10 million U.S. military personnel found the risk of developing MS shot up 32-fold after infection with Epstein-Barr, best known for causing mononucleois,

The technique detects biochemical changes in the brains of people with MS early in their disease.

A new study finds when depression and MS are together, chances of dying during the next decade are 5 times greater than if neither condition is present.

Actress Selma Blair says she’s now in remission after years of a serious multiple sclerosis flare.

A new study suggests early symptoms of multiple sclerosis may commonly be missed for years before the right diagnosis is made.

New research suggests the 'MIND' Diet -- a diet designed to boost brain health -- appears to benefit people with MS.

New research suggests the disease doesn't  raise the risk of pregnancy complications.

Many MS Patients Struggle With Finances, Forgo Treatments By Robert Preidt                HealthDay Reporter TUESDAY, Sept. 15, 2020 (HealthDay News) -- More than three-quarters of Americans with multiple sclerosis (MS) experience financial difficulties that often prevent them from getting treatment, new research claims.       "Our study results demonstrate the high prevalence of financial toxicity for MS patients and the resulting decisions patients make that impact their health care and lifestyle," said study author Dr. Gelareh Sadigh, an assistant radiology professor at Emory University School of Medicine in Atlanta.   

Obese children may be twice as likely to develop multiple sclerosis, a new study suggests.

New research revealed that patients taking a beta interferon drug for more than three years were likely to live longer than those who took one for a shorter time or who didn't take one at all.

A new Swiss study found that people who have secondary progressive MS who took the drug rituximab reported less disabling symptoms over a 10-year period than those who didn't. People taking the drug also had a slower progression of MS symptoms.

People with MS who used cannabis-derived drugs reported slightly fewer muscle contractions, less bladder dysfunction and pain in a new study. But the self-reported results differed from those doctors came up with.

The first drug approved for use in children with MS reduced relapse rates by 82 percent in people aged 10 to 17 compared with interferon beta-1a, a drug commonly used to slow the progression of the degenerative nerve disease.

Researchers have discovered a new subtype of multiple sclerosis, in which neurons die but there appears to be no damage to the myelin, the fatty, protective covering on nerve cells. The discovery changes the way scientists have understood the disease.

Researchers hope a new MRI test that tracks iron levels in the brain will help predict how fast multiple sclerosis progresses and how severe it could be.

Among those with a genetic predisposition and organic solvent exposure, MS risk rose sevenfold. About 60 percent of all the MS cases seen fell into this category.

The new guidelines, issued by the academy, took into account studies on MS drugs and concluded that it's best to start use of MS drugs as early as possible.

The treatment involves using cancer drugs to decimate a patient's immune system and then restarting it with a stem cell transplant, BBC News reported.

The current study included more than 1,100 people from Southern California. Their average age was 36. Half had been diagnosed with early MS or with clinically isolated syndrome.

The study also found that a healthy lifestyle was linked to less depression, fatigue and pain for people with MS.

These regimens raised the risk for disease relapse, study found

Latest study shows blacks and Hispanics also vulnerable